arrow_back Back to App

Global Fight Against TB: Increased US Foreign Aid for Diagnosis and Prevention.

This Act significantly boosts the United States' commitment to the global fight against tuberculosis (TB), making it a major objective of foreign assistance. It establishes new goals aligned with World Health Organization strategies, aiming to drastically reduce global TB deaths and incidence by 2035. The legislation focuses on accelerating diagnosis, treatment, and prevention efforts worldwide, indirectly enhancing global health security.
Key points
The US commits to supporting the diagnosis, treatment, and prevention of all forms of TB globally, prioritizing high-burden countries.
Funding is directed towards research and development of new vaccines and diagnostic tools, as well as reducing barriers to care, such as stigma and treatment costs.
The Act mandates strong coordination between US government agencies and international partners (like WHO) and requires detailed annual progress reports to Congress until 2030.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_288
Sponsor: Sen. Menendez, Robert [D-NJ]
Process start date: 2023-02-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

End Tuberculosis Now Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_288.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-02-07.

What are the main provisions?

Key points include:

  • The US commits to supporting the diagnosis, treatment, and prevention of all forms of TB globally, prioritizing high-burden countries.
  • Funding is directed towards research and development of new vaccines and diagnostic tools, as well as reducing barriers to care, such as stigma and treatment costs.
  • The Act mandates strong coordination between US government agencies and international partners (like WHO) and requires detailed annual progress reports to Congress until 2030.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Menendez, Robert [D-NJ].

What is the latest detailed status?

The latest detailed status is: Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S6317-6318)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health